Literature DB >> 12733686

Canadian perspectives in glaucoma management: setting target intraocular pressure range.

Karim F Damji1, Rama Behki, Lan Wang.   

Abstract

There is an abundance of evidence from recent randomized clinical trials showing that lowering the IOP is beneficial to the optic nerve and visual field. Setting and achieving a target IOP range is in keeping with evidence-based medicine. The benefits of reaching this target must be weighed against the risks of the treatment itself. Target IOP is a dynamic concept, needing constant reevaluation. What is lacking are established guidelines for determining the target IOP range that can be used in general ophthalmology practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12733686     DOI: 10.1016/s0008-4182(03)80060-1

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  26 in total

Review 1.  Chronic open-angle glaucoma. Review for primary care physicians.

Authors:  Feisal A Adatia; Karim F Damji
Journal:  Can Fam Physician       Date:  2005-09       Impact factor: 3.275

2.  Evidence of BrdU-positive retinal neurons after application of an Alpha7 nicotinic acetylcholine receptor agonist.

Authors:  Mark K Webster; Cynthia A Cooley-Themm; Joseph D Barnett; Harrison B Bach; Jessica M Vainner; Sarah E Webster; Cindy L Linn
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

3.  A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model.

Authors:  Kazuhiro Iwamoto; Patrick Birkholz; Austin Schipper; David Mata; David M Linn; Cindy L Linn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-24       Impact factor: 4.799

4.  The effect of appointment rescheduling on monitoring interval and patient attendance in the glaucoma outpatient clinic.

Authors:  A Tatham; I Murdoch
Journal:  Eye (Lond)       Date:  2012-03-02       Impact factor: 3.775

5.  Comparison of long-term results of trabeculectomy and phacotrabeculectomy in patients with pseudoexfoliation glaucoma and primary open-angle glaucoma: a single-center study.

Authors:  Büşra Yilmaz Tugan; Nursen Yuksel; Enes Kesim; Sevgi Subasi
Journal:  Int Ophthalmol       Date:  2022-01-27       Impact factor: 2.031

6.  Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.

Authors:  David Mata; David M Linn; Cindy L Linn
Journal:  Neuropharmacology       Date:  2015-07-31       Impact factor: 5.250

7.  Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS).

Authors:  Anthony J King; Jemma Hudson; Gordon Fernie; Ashleigh Kernohan; Augusto Azuara-Blanco; Jennifer Burr; Tara Homer; Hosein Shabaninejad; John M Sparrow; David Garway-Heath; Keith Barton; John Norrie; Alison McDonald; Luke Vale; Graeme MacLennan
Journal:  BMJ       Date:  2021-05-12

Review 8.  Advanced glaucoma: management pearls.

Authors:  Girum W Gessesse; Karim F Damji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

9.  Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension.

Authors:  Cindy Hutnik; David Neima; Fahim Ibrahim; Robert Scott; Julie Vaillancourt; Denis Haine; John S Sampalis; Natacha Bastien; Sylvain Foucart
Journal:  Clin Ophthalmol       Date:  2010-07-21

10.  Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.

Authors:  Sadhana V Kulkarni; Karim F Damji; Yvonne M Buys
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.